The hexosamines are a class of amino sugars in which the hydroxyl radicle attached to the second carbon atom of the hexose molecule is replaced by an amino group. The most important representatives in man of this class -of compounds are glucosamine and galactosamine. Hexosamines play an important structural role in the body, being present in the ground substance of all connective tissues as components of mucopolysaccharides and mucoproteins (Meyer, 1938; Meyer and Rapport, 1951; Consden, Glynn and Stanier, 1953 (West, Clarke and Kennedy, 1938; Weisbrod, 1950; Weiden, 1958; Jakab, 1963). Pannella and Marinucci (1959) found raised values in epithelial neoplasms with the most marked elevations occurring in cases of carcinoma of the lung. Raised serum hexosamine levels were reported in a series of patients with gastric carcinoma
of the total plasma protein and the ratio of glucosamine to galactosamine is approximately 10 to 1. All known glycoproteins contain hexosamines, which thus occur in a, /?, and y-globulins, macroglobulins, fibrinogen, orosomucoid, haptoglobins, and numerous other fractions including the blood-group substances (Putnam) , 1965 . The level of serum hexosamines is an approximate index of the total serum glycoprotein content (Winzler, 1960) . Hexosamine values in serum can readily be estimated by a colorimetric technique first described by Elson and Morgan (1933) .
Several studies of serum hexosamine levels in normal individuals have been made but many of these were based on small numbers of subjects. (West, Clarke and Kennedy, 1938; Weisbrod, 1950; Weiden, 1958; Jakab, 1963) . Pannella and Marinucci (1959) found raised values in epithelial neoplasms with the most marked elevations occurring in cases of carcinoma of the lung. Raised serum hexosamine levels were reported in a series of patients with gastric carcinoma (Scalvini, 1961) , and in lupus erythematosus and macroglobulinaemia (Weiden, 1958) . High values have also been found in rheumatic fever (Rosenberg and Schloss, 1949;  Kelley, 1952) and in rheumatoid arthritis and asthma (Jimenez Diaz, Aguirre and Arjona, 1953) . There is evidence of increased levels in pneumonia (Nilsson, 1937 ; Faber, 1948) and after trauma (West et al., 1938 ; Schlamowitz, de Graff and Schubert, 1950; Boas and Peterman, 1953) . Weiden (1960) found that in 5 out of 6 patients with untreated Hodgkin's disease the serum hexosamine level was markedly elevated at over 200 mg./100 ml., and suggested that this estimation might be a valuable aid in the diagnosis of Hodgkin's disease Weiden found in 1 patient with Hodgkin's disease who was studied serially that the serum hexosamine level fell to near-normal after successful treatment with nitrogen mustard. She suggested that serial estimations might be useful for following the therapeutic response and for the early detection of recrudescent activity.
As a raised level of hexosamines in the serum has been reported in a large number of apparently unrelated conditions, the diagnostic value of this estimation must be limited. However, like many other investigations, it may prove useful if only in particular clinical situations, as it appears that relatively few diseases are associated with gross elevations. On present evidence (Weiden, 1958 (Weiden, , 1960 these include Hodgkin's disease, collagen diseases and macroglobulinaemia.
Apart from a possible value as a diagnostic aid, this alteration of amino sugar metabolism in disease is of fundamental interest. The group of seemingly unrelated disorders in which the alteration is most marked may possess unsuspected common factors, or alternatively many separate factors may influence hexosamine metabolism to bring about similar results. The relative importance of these factors may vary in different disease states, and thus diseases or groups of diseases may produce characteristic patterns of altered serum hexosamine level. The present paper reports our investigations of this possibility.
PATIENTS.
Blood samples were obtained from hospital patients. Both inpatients and outpatients were tested. Only patients in whom a diagnosis had been firmly established by biopsy or necropsy were included in the final results. As many untreated patients as possible were included in the survey in order to avoid unpredictable effects of therapy. The patients were on a free diet, as food does not affect the serum hexosamine level (Weiden, 1958 Weiden (1958) , modified by the use of a spectrophotometer as previously described (Spiers and Malone, in preparation).
RESULTS
The results are summarized as a series of scattergrams ( Fig. 1-5 ).
Malignant lymphoma (Fig. 1.) There appears to be no significant difference between the patterns obtained for follicular lymphoma and lymphosarcoma. In both categories a majority of patients had serum hexosamine values within the normal range. No difference is seen between treated and untreated cases. In Hodgkin's disease, only 27% of all patients or 17 % of the untreated patients had levels in the normal range. The highest hexosamine values in the lymphoma group were found in Hodgkin's disease, which is also the only malignant lymphoma with a substantial number of readings above 140 mg./100 ml. It is evident from Fig relation between the hexosamine level and treatment in Hodgkin's disease. In the category of reticulum cell sarcoma only 30 % of cases had normal hexosamine values but the number of results is too small to decide whether this disease produces a pattern different from that of follicular lymphoma or lymphosarcoma.
Leaukaemia (Fig. 2.)
Hexosamine levels differing significantly from normal were not found in any of the patients with chronic lymphatic leukaemia. Only 30 % of the cases of chronic granulocytic leukaemia and none of the cases of chronic granulocytic leukaemia in acute transformation had normal levels, but the numbers involved were small. In the acute leukaemia group, a majority of treated patients and a minority of untreated patients had normal values. This possible effect of therapy was not apparent in the other types of leukaemia. When the patients with acute leukaemia were considered by age rather than treatment status, it was seen that most of the adult cases (over 15 years old) had elevated values whereas most of the childhood cases had normal values. There was however an overlapping of the two groups. Dysproteinaemias (Fig. 3.) Most of the cases of y-myeloma and of Bence Jones proteinaemia showed only slight elevations of the serum hexosamine level, whereas gross elevations were found in the patients with ,8 2A-myeloma, and with macroglobulinaemia. In the macroglobulinaemia group, results were similar in patients where the disease was primary and in those where macroglobulinaemia was secondary to frank lymphosarcoma. In 1 patient with primary macroglobulinaemia large quantities of cryoglobulins were present. When these were allowed to precipitate at room temperature, the hexosamine content of the supernatant serum was 114-6 mg./ 100 ml. When the estimation was repeated taking an aliquot from serum kept at 37°C., the level was 185.6 mg./100 ml., indicating that 38% of the total hexosamine content, or nearly all the excess hexosamine, was present in the cryoglobulin fraction.
A group of patients with idiopathic Coombs-positive acquired haemolytic anaemia was studied because this disease may be an example of disturbed globulin production without neoplasia. These were compared with the results in patients with haemolytic anaemia due to corpuscular defects (hereditary spherocytosis, -paroxysmal nocturnal haemoglobinuria, and hereditary non-spherocytic haemolytic anaemia types I and II). In most of these patients the hexosamine value was normal. There was no difference between the two groups of haemolytic anaemias and no similarity to the patterns of results seen in the patients with myeloma or macroglobulinaemia. Carcinomas and Melanoma (Fig. 4) . It was not feasible to consider all the epithelial neoplasms as separate groups according to their very numerous sites of origin. However, carcinomas of the breast and lung were considered as separate groups because these neoplasms are common. The miscellaneous group (Fig. 4) (Fig. 4, solid circles) mononucleosis. No definitive diagnoses were reached in the remaining patients. The small number of patients with collagen disease included cases of Sj6gren's syndrome, rheumatoid arthritis and systemic lupus erythematosus. Elevations of variable degree were found in most patients. A group of mongols without other disease was studied because Down's syndrome is associated with a generalised laxity of connective tissue and abnormal hypermobility of joints (Benda, 1950) , and this might indicate an abnormal mucopolysaccharide metabolism. The results (Fig. 5) suggest that mongols may have a mean value and normal range of serum hexosamine levels different from that of the general population, which would be in accord with the results of a number of other biochemical investigations in Down's syndrome (Mellman et al., 1964; Baikie et al,. 1965; Rosner et al., 1965) . No definite conclusions could be drawn from the results of hexosamine estimations in a miscellaneous group of noninfective conditions (Fig. 5, column 4 ).
In patients with burns (represented by solid triangles) levels were usually normal. Several patients with recent myocardial infarction (represented by open circles) had slightly elevated values. One out of 4 patients with sarcoidosis (represented by asterisks) had a raised serum hexosamine, as did 1 out of 4 patients with myelofibrosis (represented by solid circles). Normal or near-normal levels were found in a small number of patients (not included in the scattergram) with congestive cardiac failure, alcoholic cirrhosis, hepatitis and peptic ulcer.
DISCUSSION
From the results presented it seems certain that the estimation of the serum hexosamine level can have only limited value as an aid to diagnosis. In every disease state we have studied there have been some cases with normal hexosamine levels, thus the finding of a normal value cannot serve to exclude any of these conditions. Similarly, elevated levels of up to 140 mg./100 ml. were found in some cases of all the conditions studied except chronic lymphatic leukaemia. It is obvious that the finding of a hexosamine level in this range cannot aid in differentiating neoplasms from one another or from infective disease. Such a result indicates that disease is present but may be as nonspecific as the finding of an elevated erythrocyte sedimentation rate. When serum hexosamine levels above 160 mg./100 ml. are considered, many of the cases encountered are likely to have Hodgkin's disease, / 2A-myeloma, or macroglobulinaemia, but the specificity of this result is still low, as similar levels are recorded in occasional cases of infection, carcinoma, or collagen disease. Study of a larger series of cases of myeloma may show the serum hexosamine estimation to have some application in distinguishing , 2A-myeloma from y -myeloma when facilities for immunoelectrophoresis or ultracentrifugation are not available. In patients with clinical features of Hodgkin's disease in whom no histological confirmation can be obtained from lack of accessible abnormal lymph node tissue, the finding of a serum hexosamine level above 160 mg./ 100 ml. might be considered strong supportive diagnostic evidence. Apart from special clinical situations of this type, the diagnostic value of the test seems small.
Of more interest is a condiseration of the possible factors underlying the observed alterations in serum hexosamine levels. In normal individuals the serum hexosamine content depends principally on the level of serum glycloproteins (Winzler, 1960) . One possible explanation of altered hexosamine levels in disease is that this is a reflection of increased glycoprotein production. In systemic lupus erythematosus, the hexosamine level is elevated, and falls when the disease responds to adrenal corticosteroid therapy (Boas and Soffer, 1951 ). The fall in hexosamine level correlates with a reduction in hypergammaglobulinaemia (Boas and Reiner, 1951) , and it is therefore reasonable to postulate that the raised serum hexosamine in this disease is due to an altered plasma protein pattern. It seems likely that the gross increases of serum hexosamine in cases of /8 2A-myeloma and macroglobulinaemia are similarly due to excessive production of an abnormal hexosamine-containing protein. In one patient with macroglobulinaemia in the present series, it was demonstrated that the excess hexosamine separated out from the plasma with the cryoglobulin fraction.
A second possible cause of elevated hexosamine levels in neoplastic disease was postulated by Shetlar and co-workers (1950) who attributed the rise to active cellular proliferation. Gasic and Gasic (1962) have demonstrated the presence of hexosamines in the cell coating of tumour cells, and it is not unlikely that rapid proliferation of such tumour cells would result in an increased hexosamine turnover. This hypothesis does not of course explain the abnormal hexosamine levels found in several non-neoplastic conditions, nor is it a convincing explanation of the elevations reported by Pannella and Marinucci (1961) in patients with benign intestinal polyps.
Cellular necrosis, as well as proliferation, is a feature of many malignant tumours. Seibert and co-workers (1947) considered that the necrotic processes in tumours were important in the production of raised serum hexosamine levels, and Weiden (1958 and Weiden ( , 1960 thought that the patchy cellular necrosis often seen in Hodgkin's disease might account for the high values she observed. This hypothesis seems inadequate to explain the frequently elevated hexosamine level in conditions such as myeloma and acute leukaemia, where extensive cellular necrosis is not a feature.
One factor common to all the conditions in which raised levels of serum hexosamine have been reported is alteration, destruction, or proliferation of connective tissue, which occurs in infections, trauma, neoplastic infiltration, and collagen diseases. It is possible that a raised serum hexosamine is simply a nonspecific index of connective tissue injury and/or repair, as with either process an increased hexosamine turnover might be reflected by raised blood levels. It has been shown (Boas and Peterman, 1953 ) that in animals serum hexosamine levels are raised during periods of active growth when the mass of mesenchymal tissue is increasing rapidly, and also after several types of trauma. In infections such as cellulitis, and after mechanical injury, necrosis and lysis of connective tissue may release excessive amounts of hexosamines into the circulation. An increased synthesis of mucopolysaccharides in the ground substance of connective tissue may be the mechanism of raised hexosamine levels in proliferative tissue responses. In rheumatoid arthritis, the proliferation of synovial cells may affect the circulating hexosamine level, as these cells have been shown (Kling, Levine and Wise, 1955; Grossfield, Meyer and Godman, 1955) to produce free hyaluronic acid.
An explanation of raised serum hexosamine levels in terms of altered connective tissue metabolism cannot, however, readily account for the observations made in cases of neoplastic disease. In the present investigation it was striking that in the patients with cancer the degree of elevation of the hexosamine level appeared in no way related to the number, extent or size of metastases and hence the degree of connective tissue involvement. Widely differing values were found in patients with equal metastatic involvement, even when the same histological type of tumour was present. Some further factor is needed to explain these findings. The explanation may lie in the synthetic activity of cells in some tumours. Armin (1963) has demonstrated the production of large amounts of mucoid material in cultures of Hodgkin's tissue. If secretory activity of this type occurs in Hodgkin's disease in vivo, this may well explain why the serum hexosamine in patients with Hodgkin's disease is frequently higher than in patients with equally widespread involvement by other lymphomatous neoplasms. Within any one histological category of neoplasms, differences in the serum hexosamine level between individual cases mav depend at least as much on the metabolic activities of the tumour cells as on the total mass of tumour tissue or the extent of tumour spread in the body.
